Biological and Behavioral Outcomes of Community Nature Walks

Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorCharlotte Tate

About this trial

The investigators will test the efficacy of our proposed intervention to reduce embodied stress in four racial/ethnic groups (Black, Latinx, Pilipinx, and Pacific Islander) as a preventative intervention for health disparities found in these communities. The intervention is comprised of two phases. The first consists of community nature walks in a pristine redwood forest for six months. This is followed by chosen nature activities with family and/or friends for three months. The investigators will test the ability of these activities in nature to reduce chronic stress that underpins many health disparities using validated biological, behavioral, and sociocultural measures. The use of these measures is in alignment with the National Institute of Minority Health and Health Disparities (NIMHD) Research Framework, and will increase understanding of individual, interpersonal, community, and social level factors that lead to, and that can eliminate health disparities.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18 years or older

able to commit to a 9-month Nature Intervention (6-month walks; 3-month chosen nature activity)

spoken languages: English, Spanish, or Tagalog

able-bodied as in must be able to walk.

Disqualifiers

pregnant women (and other gender identities who are pregnant)

prisoners

cognitively impaired

Trial design

Design model

Sequential

Treatments tested in this trial

  • Reclaiming Nature Intervention

    Behavioral

    The purpose of the community intervention is to prevent health disparities in Black, Latinx, Pilipinx, and Pacific Islander communities of San Francisco, California.

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Waitlist ControlOther 1 intervention

Trial outcomes

Primary outcomes

1

Relative Telomere Length

Relative Telomere Length in the name of the outcome measure.

Time frame
Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention

Secondary outcomes

1

Hair cortisol concentration

Hair cortisol concentration in the name of the outcome measure.

Time frame
Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention
2

Self-reported stress (extent of)

Cohen Stress Scale (Likert-type self-reported measurement) in the name of the outcome measure.

Time frame
Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention
3

Positive mood (extent of)

Positive And Negative Affect Scale International version (PANAS-I) (Likert-type self-reported measurement)

Time frame
Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention

Other outcomes

1

Steps (number of)

total number of steps per day, assessed by Apple's Health Application on phones in the name of the outcome measure.

Time frame
Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention
2

Heart rate (average of beats per minute over days)

average beats per minute over days assessed by rate hear application on phones

Time frame
Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention
3

Sleep quality (extent of)

14-item Sleep Questionnaire (Likert-type self-reported measurement)

Time frame
Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Charlotte Tate

Lead sponsor

San Francisco State University

Sponsor institution

University of California, San Francisco

Collaborator